Citation: Bh. Gray, HOSPITAL CONVERSIONS FROM FOR-PROFIT TO NONPROFIT STATUS - THE OTHER SIDE OF THE STORY - COMMENTARY, Medical care research and review, 55(3), 1998, pp. 309-313
Citation: Bh. Gray et Tm. Sullivan, VASCULAR CLAUDICATION - HOW TO INDIVIDUALIZE TREATMENT, Cleveland Clinic journal of medicine, 64(8), 1997, pp. 429-436
Citation: Tm. Sullivan et al., PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND PRIMARY STENTING OF THE ILIAC ARTERIES IN 288 PATIENTS, Journal of vascular surgery, 25(5), 1997, pp. 829-838
Authors:
GRAY BH
SULLIVAN TM
CHILDS MB
YOUNG JR
OLIN JW
Citation: Bh. Gray et al., HIGH-INCIDENCE OF RESTENOSIS REOCCLUSION OF STENTS IN THE PERCUTANEOUS TREATMENT OF LONG-SEGMENT SUPERFICIAL FEMORAL-ARTERY DISEASE AFTER SUBOPTIMAL ANGIOPLASTY/, Journal of vascular surgery, 25(1), 1997, pp. 74-83
Citation: Mj. Schlesinger et al., MEDICAL PROFESSIONALISM UNDER MANAGED CARE - THE PROS AND CONS OF UTILIZATION REVIEW, Health affairs, 16(1), 1997, pp. 106-124
Authors:
LEIMAN JM
SHERZER H
STOCKER MA
MCGARVEY M
WRIGHT A
GRAY BH
Citation: Jm. Leiman et al., THE FOR-PROFIT CONVERSION OF EMPIRE-BLUE-CROSS QUESTION AND ANSWER SESSION I, Bulletin of the New York Academy of Medicine, 74(2), 1997, pp. 213-219
Citation: Bh. Gray et al., THE FOR-PROFIT CONVERSION OF EMPIRE-BLUE-CROSS - QUESTION AND ANSWER SESSION IV, Bulletin of the New York Academy of Medicine, 74(2), 1997, pp. 334-337
Authors:
DAHLBERG PS
ACTON RD
BATTAFARANO RJ
UKNIS ME
RATZ CA
JOHNSTON JW
HASEMAN JR
GRAY BH
DUNN DL
Citation: Ps. Dahlberg et al., A NOVEL ENDOTOXIN ANTAGONIST ATTENUATES TUMOR-NECROSIS-FACTOR-ALPHA SECRETION, The Journal of surgical research, 63(1), 1996, pp. 44-48
Authors:
DAHLBERG PS
ACTON RD
UKNIS ME
KLAERNER HG
JOHNSTON JW
LEVELLE CD
GRAY BH
DUNN DL
Citation: Ps. Dahlberg et al., MACROPHAGES EXPRESSING A FUSION PROTEIN-DERIVED FROM BACTERICIDAL PERMEABILITY-INCREASING PROTEIN AND IGG ARE RESISTANT TO ENDOTOXIN/, Archives of surgery, 131(11), 1996, pp. 1173-1177
Authors:
REGELMANN WE
SIEFFERMAN CM
HERRON JM
ELLIOTT GR
CLAWSON CC
GRAY BH
Citation: We. Regelmann et al., SPUTUM PEROXIDASE-ACTIVITY CORRELATES WITH THE SEVERITY OF LUNG-DISEASE IN CYSTIC-FIBROSIS, Pediatric pulmonology, 19(1), 1995, pp. 1-9
Citation: Bh. Gray et al., B PI-DERIVED SYNTHETIC PEPTIDES - SYNERGISTIC EFFECTS IN TETHERED BACTERICIDAL AND ENDOTOXIN NEUTRALIZING PEPTIDES/, Biochimica et biophysica acta (G). General subjects, 1244(1), 1995, pp. 185-190
Citation: Bh. Gray et Sr. Phillips, MEDICAL SOCIOLOGY AND HEALTH-POLICY - WHERE ARE THE CONNECTIONS, Journal of health and social behavior, 1995, pp. 170-182
Citation: Mb. King et al., THE PROTEINASE-ANTIPROTEINASE BALANCE IN ALPHA-1-PROTEINASE INHIBITOR-DEFICIENT LUNG-TRANSPLANT RECIPIENTS, American journal of respiratory and critical care medicine, 149(4), 1994, pp. 966-971
Authors:
REGELMANN AG
GRAY BH
HASEMAN JR
REGELMANN WE
Citation: Ag. Regelmann et al., ELASTIN DEGRADATION AND ITS INHIBITION BY CYSTIC-FIBROSIS BRONCHOALVEOLAR LAVAGE, Pediatric research, 35(4), 1994, pp. 10000397-10000397
Citation: Bh. Gray et Jr. Haseman, BACTERICIDAL ACTIVITY OF SYNTHETIC PEPTIDES BASED ON THE STRUCTURE OFTHE 55-KILODALTON BACTERICIDAL PROTEIN FROM HUMAN NEUTROPHILS, Infection and immunity, 62(7), 1994, pp. 2732-2739
Citation: Nv. Rao et al., INTERACTION OF SECRETORY LEUKOCYTE PROTEASE INHIBITOR WITH PROTEINASE-3, American journal of respiratory cell and molecular biology, 8(6), 1993, pp. 612-616